SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CNS Pharmaceuticals Q3 net loss narrows as R&D costs fall

CNS Pharmaceuticals Q3 net loss narrows as R&D costs fall Overview US biotechnology firm reported Q3

CNSPLRMRPRLD

Related stories